Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

Self-Assembled Ferritin Nanoparticles Expressing Hemagglutinin As An Influenza Vaccine

  • Read more about Self-Assembled Ferritin Nanoparticles Expressing Hemagglutinin As An Influenza Vaccine
US Application 61/538,663
Filed on 2011-09-23

Methods of Producing T Cell Populations Enriched for Stable Regulatory T Cells

  • Read more about Methods of Producing T Cell Populations Enriched for Stable Regulatory T Cells
US Application 61/576,837
Filed on 2011-12-16

IMMUNOGENS BASED ON AN HIV-1 V1V2 SITE-OF-VULNERABILITY

  • Read more about IMMUNOGENS BASED ON AN HIV-1 V1V2 SITE-OF-VULNERABILITY
US Application 61/533,721
Filed on 2011-09-12

PROTEASE-DEFICIENT BACILLUS ANTHRACIS

  • Read more about PROTEASE-DEFICIENT BACILLUS ANTHRACIS
US Application 61/521,617
Filed on 2011-08-09

NEUTRALIZING GP41 ANTIBODIES AND THEIR USE

  • Read more about NEUTRALIZING GP41 ANTIBODIES AND THEIR USE
US Application 61/556,660
Filed on 2011-11-07

USE OF INTERLEUKIN-7 ANTAGONISTS FOR TREATMENT OF HIV INFECTIONS

  • Read more about USE OF INTERLEUKIN-7 ANTAGONISTS FOR TREATMENT OF HIV INFECTIONS
US Application 61/667,748
Filed on 2012-07-03

Treatment And Prevention Of Tuberculosis Via Drug-Mediated Manipulation Of The Eicosanoid Balance and Treatment and Prevention of Diseases Mediated By Microorganisms Via Drug-Mediated Manipulation of the Eicosanoid Balance

  • Read more about Treatment And Prevention Of Tuberculosis Via Drug-Mediated Manipulation Of The Eicosanoid Balance and Treatment and Prevention of Diseases Mediated By Microorganisms Via Drug-Mediated Manipulation of the Eicosanoid Balance
US Application 61/515,237
Filed on 2011-08-04

Neutralizing Antibodies To HIV-1 And Their Use

  • Read more about Neutralizing Antibodies To HIV-1 And Their Use
US Application 61/522,205
Filed on 2011-08-10

Method for Inducing An Immune Response Against Avian, Swine, H1N1, H5N1 Influenza Viruses And Formulations Thereof

  • Read more about Method for Inducing An Immune Response Against Avian, Swine, H1N1, H5N1 Influenza Viruses And Formulations Thereof
US Application 61/490,050
Filed on 2011-05-25

Protease-Deficient Bacillus Anthracis

  • Read more about Protease-Deficient Bacillus Anthracis
US Application 61/514,384
Filed on 2011-08-02

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 70
  • Page 71
  • Page 72
  • Page 73
  • Page 74
  • Page 75
  • Page 76
  • Page 77
  • Page 78
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health